Health-related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine

Digestive Diseases and Sciences

Volumn 46, Issue 11, 2001, Pages 2416-2423

  Mathias, Susan D ^a   Colwell, Hilary H ^a   Miller, Dave P ^a   Pasta, David J ^a   Henning, James M ^b   Ofman, Joshua J ^c  

^a Lewin Group   (United States)

^b TAP Holdings Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GERD; Health related quality of life; Lansoprazole; Questionnaire

Indexed keywords

LANSOPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SYMPTOM; WORK DISABILITY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; OMEPRAZOLE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RANITIDINE; SOCIOECONOMIC FACTORS;

EID: 0034761211     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012363501101     Document Type: Article

References (20)

1. Guidelines for diagnosis and treatment of gastroesophageal reflux disease
2. Treatment of gastroesophageal (acid) reflux with lansoprazole: An overview
3. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
4. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines
5. Practical pointers for grappling with GERD: Heartburn gnaws at quality of life for many patients
6. The health-related quality of life of patients with acute erosive reflux esophagitis
7. Treating symptoms of gastro-oesophageal reflux disease: A double-blind comparison of omeprazole and cisapride
8. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: A clinical experience network (CEN) study
9. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicenter clinical trial
10. The impact of gastroesophageal reflux disease on health-related quality of life
11. Use of the Short Form-36 to detect the influence of upper gastrointestinal disease on self-reported health status
12. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases
13. Quality-days incrementally gained (QDIG): A new approach for short-term evaluations based on the extended Q-TWiST (EQT) method illustrated in a clinical study of reflux disease patients
14. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease
15. Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: A validation study
16. Coefficient alpha and the internal structure of tests
17. Instrument review criteria
18. A comparison of two approaches for assessing patient importance weights to conduct an Extended Q-TWiST analysis
19. Older patient's health status and satisfaction with medical care in an HMO population